E-GuARD: expert-guided augmentation for the robust detection of compounds interfering with biological assays

Assay interference caused by small organic compounds continues to pose formidable challenges to early drug discovery. Various computational methods have been developed to identify compounds likely to cause assay interference. However, due to the scarcity of data available for model development, the predictive accuracy and applicability of these approaches are limited. In this work, we present E-GuARD, a novel framework seeking to address data scarcity and imbalance by integrating self-distillation, active learning, and expert-guided molecular generation. E-GuARD iteratively enriches the training data with interference-relevant molecules, resulting in quantitative structure-interference relationship (QSIR) models with superior performance. We demonstrate the utility of E-GuARD with the examples of four high-quality data sets on thiol reactivity, redox reactivity, nanoluciferase inhibition, and firefly luciferase inhibition. Our models reached MCC values of up to 0.47 for these data sets, with two-fold or higher improvements in enrichment factors compared to models trained without E-GuARD data augmentation. These results highlight the potential of E-GuARD as a scalable solution to mitigating assay interference in early drug discovery. SCIENTIFIC CONTRIBUTION: We present E-GuARD, an innovative framework that combines iterative self-distillation with guided molecular augmentation to enhance the predictive performance of QSAR models. By allowing models to learn from newly generated, informative compounds through iterations, E-GuARD facilitates the understanding of underrepresented structural patterns and improves performance on unseen data. When applied across different interference mechanisms, E-GuARD consistently outperformed standard approaches. E-GuARD establishes the foundation for further research into dynamic data enrichment and more robust molecular modeling.

Authors

Institutions

Publication Details

Journal
Journal of Cheminformatics
Published
2025-04-29
DOI
https://doi.org/10.1186/s13321-025-01014-3
Citations
1
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

E-GuARD: expert-guided augmentation for the robust detection of compounds interfering with biological assays

Samuel Kaski, Matthias Welsch, Vincenzo Palmacci, Johannes Kirchmair et al.
1 citations
Journal of Cheminformatics
Computational Drug Discovery Methods
1.50
article

E-GuARD: expert-guided augmentation for the robust detection of compounds interfering with biological assays

Samuel Kaski, Matthias Welsch, Vincenzo Palmacci, Johannes Kirchmair, Ola Engkvist, Yasmine Nahal
article en
1 citations

Abstract

Assay interference caused by small organic compounds continues to pose formidable challenges to early drug discovery. Various computational methods have been developed to identify compounds likely to cause assay interference. However, due to the scarcity of data available for model development, the predictive accuracy and applicability of these approaches are limited. In this work, we present E-GuARD, a novel framework seeking to address data scarcity and imbalance by integrating self-distillation, active learning, and expert-guided molecular generation. E-GuARD iteratively enriches the training data with interference-relevant molecules, resulting in quantitative structure-interference relationship (QSIR) models with superior performance. We demonstrate the utility of E-GuARD with the examples of four high-quality data sets on thiol reactivity, redox reactivity, nanoluciferase inhibition, and firefly luciferase inhibition. Our models reached MCC values of up to 0.47 for these data sets, with two-fold or higher improvements in enrichment factors compared to models trained without E-GuARD data augmentation. These results highlight the potential of E-GuARD as a scalable solution to mitigating assay interference in early drug discovery. SCIENTIFIC CONTRIBUTION: We present E-GuARD, an innovative framework that combines iterative self-distillation with guided molecular augmentation to enhance the predictive performance of QSAR models. By allowing models to learn from newly generated, informative compounds through iterations, E-GuARD facilitates the understanding of underrepresented structural patterns and improves performance on unseen data. When applied across different interference mechanisms, E-GuARD consistently outperformed standard approaches. E-GuARD establishes the foundation for further research into dynamic data enrichment and more robust molecular modeling.

Journal of CheminformaticsVol. 17(1)
University of Vienna (AT), University of Manchester (GB), Christian Doppler Laboratory for Thermoelectricity (AT), AstraZeneca (Sweden) (SE), Chalmers University of Technology (SE), BOKU University (AT), Aalto University (FI)
UK Research and Innovation, European Commission, Universität Wien, Finnish Center for Artificial Intelligence
Good health and well-being
Openalex Percentile: Top 17%
Computational Drug Discovery Methods
1.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.